PKLR and prostate neoplasm: The IHC analysis showed higher levels of PKLR in prostate tumors in patients who received ADT compared to the same patients before ADT; however, ZBTB10 levels were higher in patients before ADT and lower in patients after ADT (Fig. 2G, H).